IGF-1 LR3 | 1mg | Long-Arginine Analog of Insulin-Like Growth Factor-1

For In Vitro Research Use Only — Not for Human or Veterinary Use

Description
IGF-1 LR3 (Insulin-Like Growth Factor 1 Long Arg3) is a synthetic peptide analog of human IGF-1 engineered to exhibit greater biological stability and extended half-life. This modification enhances receptor binding efficiency and allows for prolonged activity during in vitro study.
In scientific research, IGF-1 LR3 is frequently utilized in cellular growth assays, anabolic pathway modeling, and studies related to protein synthesis, differentiation, and tissue regeneration. This 1mg lyophilized formulation is specifically designed for advanced laboratory research applications.

Specifications

• Unit Size: 1mg
• Form: Lyophilized powder
• Storage: Store in a cool, dry environment between 2°C–8°C. After reconstitution, refrigerate and use within 10–14 days.
• Solubility: Soluble in sterile or bacteriostatic water

Research Applications
IGF-1 LR3 is widely studied in in vitro research investigating:

• Cellular growth and proliferation pathways

• Protein synthesis and anabolic signaling

• Myogenesis and skeletal muscle cell development

• Insulin receptor and IGF receptor cross-talk mechanisms

Intended Use
This compound is intended strictly for in vitro laboratory research conducted by qualified professionals. It is not approved for human or animal use and may not be used in food, drugs, cosmetics, or diagnostic materials.

⚠️ Legal Disclaimer
All products from Pacific Edge Labs are intended solely for laboratory research and educational purposes. These compounds have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Use is restricted to licensed research institutions and authorized professionals.

Terms of Sale
By purchasing from Pacific Edge Labs, the buyer confirms they are a qualified researcher or institution responsible for the safe handling, storage, and lawful use of laboratory materials. All sales are final.